TALMEDICA · MEDICAL AFFAIRS ADVISORY
Is your Medical Affairs model built for the market you're in?
A first launch. An inherited Field Medical team. A headcount decision with a deadline. Most Medical Affairs organizations are making these calls on operating assumptions the market has already moved past.
When decisions can't wait, building the expertise or capacity internally isn't always an option. Talmedica provides independent assessments and fractional leadership to determine what needs to change, then stays to lead the work through handoff.
Request an advisory discussionHOW WE HELP
Medical Affairs strategy, organizational design, and capabilities
UNDERSTAND WHAT'S HAPPENING
Assessments & Organizational Readiness
Leaders call us when they're:
New in the seat, inheriting a team they didn't build
Facing a headcount or budget decision
Reorganizing and deciding what to protect
Evaluating or renewing an AI insights tool
Independent review of Field Medical deployment, capabilities, insight flow, and cross-functional alignment.
You get: findings, prioritized risks, resourcing options, and a 90-day action plan.
HELP LEAD THE WORK
Fractional Medical Affairs Leadership
Leaders call us when they're:
Preparing for a first launch, ideally 18 months out
Needing interim or transitional leadership or capability
Rolling out a new capability, technology, or operating model
Senior Medical Affairs leadership in the seat for a defined period. Talmedica sets the priorities, makes the calls within an agreed scope, and stays through execution and handoff.
You get: owned workstreams, decision governance, execution milestones, and a documented handoff.
STRENGTHEN THE LEADER
Leadership Advisory
Leaders call us when they're:
Stepping into a first Head-level role
Leading a team through a difficult transition
Working through a hard cross-functional situation
Experienced 1:1 counsel for the decisions new leaders can't easily take to their own organization.
You get: structured sessions over three months, decision support, and a leadership action plan, with your manager aligned at kickoff and close.
Advisory for Medical Affairs technology and service providers →
BEFORE TALMEDICA
Experience Behind Talmedica
Before founding Talmedica, Christine Ong spent 20+ years across drug development and Medical Affairs, building Field Medical organizations, preparing launches, and redesigning teams. These examples come from her industry leadership roles. They show the kinds of problems Talmedica is hired to solve today.
Pre-launch Field Medical design
Designed a pre-launch Field Medical function as a center of excellence instead of a geographically dispersed MSL team. Built a local resistance-data engagement approach that addressed infectious disease specialists' stewardship concerns, improving field engagement and insight collection.
Refocusing an existing team on payer-relevant evidence
Led a 12-person Field Medical team for a later-to-market biologic in a crowded immunology class and shifted its focus toward payer-relevant evidence. Partnered with Market Access and HEOR on a patient subpopulation analysis.
Finding the barrier no one was naming
Dermatologists weren't raising psoriatic arthritis with patients, and the gap wasn't awareness. It was care friction they hadn't fully seen: a difficult diagnosis, then long rheumatology wait times while joint damage progressed. Built support for a program that reframed early PsA recognition around that reality, with dermatology and rheumatology experts and patients. MSL insight data subsequently showed more PsA discussions with dermatologists.
WHY TALMEDICA
An outside view, from someone who has run the inside
Talmedica was founded by Christine Ong, PharmD, whose experience spans early drug development, regulatory strategy, and Medical Affairs leadership. Having built and led Field Medical teams through launches, transitions, and organizational change, she brings an independent perspective informed by the decisions and constraints leaders face inside pharmaceutical organizations.
20+ years across pharma and biotech
Experience spanning scientific development, regulatory, and Medical Affairs leadership.
Built and led Field Medical organizations
Firsthand experience with launch preparation, operating models, capability development, and organizational change.
Development through commercialization
Perspective on how upstream decisions shape what Medical Affairs eventually inherits.
PHARMA SIGNAL
What the market is signaling for Medical Affairs
Pharma Signal examines the decisions, assumptions, and market changes shaping Medical Affairs. From Field Medical effectiveness to launch readiness and evolving HCP needs, each issue looks at where industry practice aligns with the market and where it may need to change.
LAUNCH READINESS
A Field Team Is Not a Launch Plan
Why deploying MSLs is only one part of preparing Medical Affairs for launch.
LEADERSHIP
The Leadership Transition We Don't Prepare For
What changes when experienced professionals become accountable for leading an organization.
MEDICAL AFFAIRS STRATEGY
Before You Lock Your 2027 Medical Affairs Plan
Four questions worth asking before finalizing next year's Medical Affairs priorities and resources.
Christine also writes The Pharma Insider Brief, read by 20,000+ pharmaceutical and Medical Affairs professionals on LinkedIn.
Request an advisory discussion
Tell me a little about what your organization is navigating. I'll respond personally within 48 hours.